Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Argan (AGX) over the last 17 years, with Q4 2025 value amounting to $306.3 million.

  • Argan's Cash & Equivalents rose 7467.68% to $306.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $306.3 million, marking a year-over-year increase of 7467.68%. This contributed to the annual value of $145.3 million for FY2025, which is 2627.44% down from last year.
  • As of Q4 2025, Argan's Cash & Equivalents stood at $306.3 million, which was up 7467.68% from $177.8 million recorded in Q3 2025.
  • Argan's Cash & Equivalents' 5-year high stood at $451.4 million during Q3 2021, with a 5-year trough of $136.1 million in Q4 2022.
  • Over the past 5 years, Argan's median Cash & Equivalents value was $196.5 million (recorded in 2023), while the average stood at $241.0 million.
  • As far as peak fluctuations go, Argan's Cash & Equivalents surged by 11908.73% in 2021, and later tumbled by 6824.56% in 2022.
  • Over the past 5 years, Argan's Cash & Equivalents (Quarter) stood at $391.6 million in 2021, then plummeted by 65.25% to $136.1 million in 2022, then surged by 36.38% to $185.6 million in 2023, then decreased by 5.51% to $175.3 million in 2024, then skyrocketed by 74.68% to $306.3 million in 2025.
  • Its last three reported values are $306.3 million in Q4 2025, $177.8 million for Q3 2025, and $189.3 million during Q2 2025.